We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI May Benefit Decision-Making in Less Experienced Clinicians Assessing Heart Ultrasounds

By MedImaging International staff writers
Posted on 09 Sep 2024
Print article
Image: The EchoGo Pro uses AI technology to accurately and instantly predict heart disease risk through non-invasive ultrasound analysis (Photo courtesy of Ultromics)
Image: The EchoGo Pro uses AI technology to accurately and instantly predict heart disease risk through non-invasive ultrasound analysis (Photo courtesy of Ultromics)

Coronary artery disease (CAD) is a leading cause of death globally, causing over 9 million deaths worldwide and 63,000 annually in the UK alone. Stress echocardiography (SE), which is an ultrasound of the heart taken at rest and during stress, is crucial for assessing the risk of heart attacks and death in patients with known or suspected CAD. SE is not only among the most frequently used diagnostic tests for CAD but is also the primary imaging method available across the UK for this diagnosis. However, its accuracy ranges significantly, from 60% to 94%, influenced by the clinician's expertise and the quality of the images. The integration of artificial intelligence (AI) into healthcare presents significant potential to aid clinicians in diagnosing more swiftly and accurately, thus initiating treatments earlier. Now, a large randomized trial found no substantial evidence to suggest that AI assistance in clinical decision-making for heart ultrasound assessments improves detection rates compared to traditional practices for identifying patients with suspected heart disease who might benefit from invasive treatments. Nonetheless, the study highlighted that AI could enhance decision-making capabilities for less experienced clinicians and showed promise in particularly complex clinical sub-groups.

Developed by researchers at the University of Oxford (Oxford, UK) EchoGo Pro automates the interpretation of SE images by integrating novel image features with AI technology. This software's effectiveness was tested through the PROTEUS randomized controlled trial, which involved patients aged 18 and older referred for SE at 20 UK hospitals from November 2021 to June 2023 to investigate suspected CAD. The study involved 2,341 patients (average age 64 years; 45% female; 20% with pre-existing heart disease), who were randomly assigned to either standard clinical decision-making or AI-enhanced decision-making where clinicians used an AI-generated image analysis report (EchoGo Pro) during their image assessments to evaluate the likelihood of severe CAD. The main focus of the study was to compare the effectiveness of standard versus AI-augmented decision-making in directing patients towards invasive coronary angiograms and monitoring acute coronary events within a six-month period. By December 2023, 2,213 participants (94.5%) had completed the six-month follow-up.

Overall, 85 patients were referred for angiography post-SE. Among those not referred, 41 suffered acute coronary syndromes (nonfatal heart attacks) or cardiac deaths within six months, indicating potential misjudgments in referral decisions. The analysis revealed that AI-assisted decision-making did not show non-inferiority compared to traditional clinical decision-making in appropriately directing patients for coronary angiography. Among those referred, 27 out of 36 in the control group and 34 out of 49 in the AI group were deemed correct referrals. Regarding patients who suffered adverse events despite not being referred for angiography, there were 22 in the control group and 19 in the AI group, though the differences were not statistically significant. However, additional analyses indicated that AI could improve decision-making among less experienced clinicians and in complex cases where image interpretation is challenging.

“It is well reported that clinician performance in interpreting stress echocardiograms ranges widely according to the experience level of the operator,” said lead author Dr. Ross Upton from the University of Oxford. “The results of this trial suggest that AI has the potential to bring all operators, regardless of experience, up to the same level of accuracy. While the PROTEUS trial did not demonstrate meaningful differences in all-comers, the AI diagnostic may also benefit specific subgroups of patients in whom decision making is known to be more complex.”

Related Links:
University of Oxford

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Radiation Therapy Treatment Software Application
Elekta ONE
1.5T MRI Scanner
MAGNETOM Amira
Endoscopic Ultrasound Fine Needle Biopsy Device
Acquire

Print article
Radcal

Channels

MRI

view channel
Image: MRI-linac allows clinicians to see what’s going on in the brain for the first time (Photo courtesy of Sylvester Comprehensive Cancer Center)

MRI Provides Early Warning System for Glioblastoma Growth

A new study has demonstrated the potential of combining imaging with radiation to shape glioblastoma treatment in real time. The research is the first to quantify tumor changes in glioblastoma patients... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

General/Advanced Imaging

view channel
Image: A kidney showing positive [89Zr]Zr-girentuximab PET and histologically confirmed clear-cell renal cell carcinoma (Photo courtesy of Dr. Brian Shuch/UCLA Health)

Non-Invasive Imaging Technique Accurately Detects Aggressive Kidney Cancer

Kidney cancers, known as renal cell carcinomas, account for 90% of solid kidney tumors, with over 81,000 new cases diagnosed annually in the United States. Among the various types, clear-cell renal cell... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.